BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8011630)

  • 1. Inhibition of phosphomannose isomerase by mercury ions.
    Wells TN; Payton MA; Proudfoot AE
    Biochemistry; 1994 Jun; 33(24):7641-6. PubMed ID: 8011630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine.
    Wells TN; Scully P; Paravicini G; Proudfoot AE; Payton MA
    Biochemistry; 1995 Jun; 34(24):7896-903. PubMed ID: 7794901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cys-150 in the active site of phosphomannose isomerase from Candida albicans.
    Coulin F; Magnenat E; Proudfoot AE; Payton MA; Scully P; Wells TN
    Biochemistry; 1993 Dec; 32(51):14139-44. PubMed ID: 8260497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphomannose isomerase from Saccharomyces cerevisiae contains two inhibitory metal ion binding sites.
    Wells TN; Coulin F; Payton MA; Proudfoot AE
    Biochemistry; 1993 Feb; 32(5):1294-301. PubMed ID: 8448139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine 304 is an active site residue in phosphomannose isomerase from Candida albicans.
    Wells TN; Scully P; Magnenat E
    Biochemistry; 1994 May; 33(19):5777-82. PubMed ID: 8180205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of fungal and mammalian phosphomannose isomerases.
    Proudfoot AE; Payton MA; Wells TN
    J Protein Chem; 1994 Oct; 13(7):619-27. PubMed ID: 7702743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarizable water networks in ligand-metalloprotein recognition. Impact on the relative complexation energies of Zn-dependent phosphomannose isomerase with D-mannose 6-phosphate surrogates.
    Gresh N; de Courcy B; Piquemal JP; Foret J; Courtiol-Legourd S; Salmon L
    J Phys Chem B; 2011 Jun; 115(25):8304-16. PubMed ID: 21650197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Saccharomyces cerevisiae phosphomannose isomerase by the NO-donor S-nitroso-acetyl-penicillamine.
    Salvati L; Mattu M; Tiberi F; Polticelli F; Ascenzi P
    J Enzyme Inhib; 2001; 16(3):287-92. PubMed ID: 11697049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring structure-activity relationships around the phosphomannose isomerase inhibitor AF14049 via combinatorial synthesis.
    Bhandari A; Jones DG; Schullek JR; Vo K; Schunk CA; Tamanaha LL; Chen D; Yuan Z; Needels MC; Gallop MA
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2303-8. PubMed ID: 9873532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of non-hydrolyzable D-mannose 6-phosphate surrogates reveal 6-deoxy-6-dicarboxymethyl-D-mannose as a new strong inhibitor of phosphomannose isomerases.
    Foret J; de Courcy B; Gresh N; Piquemal JP; Salmon L
    Bioorg Med Chem; 2009 Oct; 17(20):7100-7. PubMed ID: 19783448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reaction mechanism of type I phosphomannose isomerases: new information from inhibition and polarizable molecular mechanics studies.
    Roux C; Bhatt F; Foret J; de Courcy B; Gresh N; Piquemal JP; Jeffery CJ; Salmon L
    Proteins; 2011 Jan; 79(1):203-20. PubMed ID: 21058398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenomethionine labelling of phosphomannose isomerase changes its kinetic properties.
    Bernard AR; Wells TN; Cleasby A; Borlat F; Payton MA; Proudfoot AE
    Eur J Biochem; 1995 May; 230(1):111-8. PubMed ID: 7601089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain organisation in phosphomannose isomerases (types I and II).
    Jensen SO; Reeves PR
    Biochim Biophys Acta; 1998 Jan; 1382(1):5-7. PubMed ID: 9507048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an Fe(III)-dihydroxyphenylalanine site in recombinant phosphomannose isomerase from Candida albicans.
    Smith JJ; Thomson AJ; Proudfoot AE; Wells TN
    Eur J Biochem; 1997 Mar; 244(2):325-33. PubMed ID: 9118997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution.
    Cleasby A; Wonacott A; Skarzynski T; Hubbard RE; Davies GJ; Proudfoot AE; Bernard AR; Payton MA; Wells TN
    Nat Struct Biol; 1996 May; 3(5):470-9. PubMed ID: 8612079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and heterologous expression of the Candida albicans gene PMI 1 encoding phosphomannose isomerase.
    Smith DJ; Proudfoot AE; Detiani M; Wells TN; Payton MA
    Yeast; 1995 Apr; 11(4):301-10. PubMed ID: 7785330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of 5-phospho-D-arabinonohydroxamate and 5-phospho-D-arabinonate inhibitors to zinc phosphomannose isomerase from Candida albicans studied by polarizable molecular mechanics and quantum mechanics.
    Roux C; Gresh N; Perera LE; Piquemal JP; Salmon L
    J Comput Chem; 2007 Apr; 28(5):938-57. PubMed ID: 17253648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro folding of a recombinant metalloenzyme, phosphomannose isomerase.
    Proudfoot AE; Goffin L; Payton MA; Wells TN; Bernard AR
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):437-42. PubMed ID: 8809030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and kinetics of metalloenzyme phosphomannose isomerase: measurement of dissociation constants and effect of zinc binding using ESI-FTICR mass spectrometry.
    Gao H; Yu Y; Leary JA
    Anal Chem; 2005 Sep; 77(17):5596-603. PubMed ID: 16131071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of phosphomannose isomerase from Candida albicans complexed with 5-phospho-d-arabinonhydrazide.
    Ahmad L; Plancqueel S; Dubosclard V; Lazar N; Ghattas W; Li de la Sierra-Gallay I; van Tilbeurgh H; Salmon L
    FEBS Lett; 2018 May; 592(10):1667-1680. PubMed ID: 29687459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.